HEALTH STATUS OF CHILDREN BORN BY WOMEN WITH ANTIPHOSPHOLIPID SYNDROME
https://doi.org/10.29235/1814-6023-2018-15-2-229-243
Abstract
Antiphospholipid syndrome (APS) is an important multidisciplinary problem, especially in obstetrics. The assessment of the health status of children born by mothers with APS is no less significant. Based on the analysis and the systematization of literature from 1987 to 2017, the modern aspects of pathogenesis and diagnostic criteria are presented; both immediate and long-term consequences of mothers’ APS influence on their offspring are considered. APS during pregnancy can lead to an increase in the incidence of pregnancy and passive transmission of antibodies to the fetus, which increases the risk of prematurity, intrauterine growth retardation (IUGR), thrombocytopenia. Antiphospholipid antibodies can influence the nervous system during the embryonic period. Circulation of antibodies in newborns is rarely able to lead to thrombosis, usually against the background of an infectious process and/or hereditary thrombophilia. The health status of newborns, born by mothers with APS, depends on the gestational age, the level of physical development, the interest of brain structures. Further, a long-term follow-up is needed to assess the health status of children in different age periods.
About the Authors
A. V. Sukalo
Belarusian State Medical University.
Belarus
Belarus
Alexander V. Sukalo – Academician, D. Sc. (Med.), Professor, Deputy Chairman of the Presidium of the National Academy of Sciences of Belarus.
83, Dzerzhynskiy Ave., 220116, Minsk.
V. A. Prilutskaya
Belarusian State Medical University.
Belarus
Belarus
Veronica A. Prilutskaya – Ph. D. (Med.), Assistant Professor.
83, Dzerzhynskiy Ave., 220116, Minsk.
M. I. Zoryna
Belarusian State Medical University.
Russian Federation
Russian Federation
Margarita I. Zoryna – Student.
83, Dzerzhynskiy Ave., 220116, Minsk.
References
1. Gómez-PuertaJ. A., Cervera R. Diagnosis and classification of the antiphospholipid syndrome. Journal of Autoimmunity, 2014, vol. 48–49, pp. 20–25. DOI: 10.1016/j.jaut.2014.01.006
2. Lockshin M. D. Update on antiphospholipid syndrome. Bulletin of the NYU Hospital for Joint Diseases, 2006, vol. 66, no. 3, pp. 195–197.
3. Di Prima F. A., Valenti O., Hyseni E., Giorgio E., Faraci M., Renda E., De Domenico R., Monte S. Antiphospholipid Syndrome during pregnancy: the state of the art. Journal of Prenatal Medicine, 2011, vol. 5, no. 2, pp. 41–53.
4. Ateka-Barrutia, O., Khamashta M. A. The challenge of pregnancy for patients with SLE. Lupus, 2013, vol. 22, no. 12, pp. 1295–1308. DOI: 10.1177/0961203313504637
5. Miyakis S., Lockshin M. D., Atsumi T., Branch D. W., Brey R. L., Cervera R., Derksen R. H. W. M., de Groot P. G., Koike T., Meroni P. L., Reber G., Shoenfeld Y., Tincani A., Vlachoyiannopoulos P. G., Krilis S. A. International consensus statement on an update of the classification criternia for definite antiphospholipid syndrome (APS). Journal of Thrombosis and Haemostasis, 2006, vol. 4, no. 2, pp. 295–306. DOI: 10.1111/j.1538-7836.2006.01753.x
6. Holers V. M., Girardi G., Mo L., Guthridge J. M., Molina H., Pierangeli S. S., Espinola R., Xiaowei L. E., Mao D., Vialpando Ch. G., Salmon J. E. Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. Journal of Experimental Medicine, 2002, vol. 195, no. 2, pp. 211–220. DOI: 10.1084/jem.200116116
7. Giannakopoulos, B. Krilis S. A. The pathogenesis of the antiphospholipid syndrome. New England Journal of Medicine, 2013, vol. 368, no. 11, pp. 1033–1044. DOI: 10.1056/NEJMra1112830
8. Hanly J. G. Antiphospholipid syndrome: an overview. CMAJ, 2003, vol. 168, no. 13, pp. 1675–1682.
9. Tincani A., Rebaioli Ch. B., Andreoli L., Lojacono A., Motta M. Neonatal effects of maternal antiphospholipid syndrome. Current Rheumatology Reports, 2009, vol. 11, no. 1, pp. 70–76. DOI: 10.1007/s11926-009-0010-8
10. Di Simone N., Meroni P. L., del Papa N., Raschi E., Caliandro D., de Carolis S., Khamashta M. A., Atsumi T., Hughes G. R. V., Balestrieri G., Tincani A., Casali P., Caruso A. Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein I. Arthritis and Rheumatism, 2000, vol. 43, no. 1, pp. 140–150. DOI: 10.1002/1529-0131(200001)43:1<140::AID-ANR18>3.0.CO;2-P
11. Nalli C., Iodice A., Andreoli L., Lojacono A., Motta M., Fazzi E., Tincani A. The effects of lupus and antiphospholipid antibody syndrome on foetal outcomes. Lupus, 2014, vol. 23, no. 6, рр. 507–517. DOI: 10.1177/0961203313501402
12. Kharkevich O. N., Latnikova E. A. Care in pregnancy childbirth in patients with antiphospholipid syndrome. Meditsinskie novosti [Medical News], 2011, no. 2, pp. 51–59 (in Russian).
13. Van Horn J. T., Craven C., Ward K., Branch D. W., Silver R. M. Histologic features of placentas and abortion specimens from women with antiphospholipid and antiphospholipid-like syndromes. Placenta, 2004, vol. 25, no. 7, pp. 642–648. DOI: 10.1016/j.placenta.2003.12.006
14. Otaduy C., Alba P. B., Gobbi C. A., Alvarez A., Albiero A., Albiero E. H., Propato M. L., Yorio M. A. AB0485 Primary antiphospholipid syndrome: maternal and fetal outcome. Аnnals Rheumatic Diseases, 2017, vol. 76, suppl. 2, pp. 1220–1221. DOI: 10.1136/annrheumdis-2017-eular.5621
15. Moroni G., Doria A., Giglio E., Tani Ch., Zen M., Strigini F., Zaina B., Tincani A., de Liso F., Matinato C., Grossi C., Gatto M., Castellana P., Limardo M., Meroni P. L., Messa P., Ravani P., Mosca M. Fetal outcome and recommendations of pregnancies in lupus nephritis in the 21st century. A prospective multicenter study. Journal of Autoimmunity, 2016, vol. 74, pp. 6–12. DOI: 10.1016/j.jaut.2016.07.010
16. Kosheleva N. M., Alekberova Z. C. Neonatal lupus. Sovremennaya revmatologiya [Modern Rheumatology], 2015, vol. 9, no. 4, pp. 92–97 (in Russian).
17. Nili F., McLeod L., O’Connell C., Sutton E., McMillan D. Outcomes of pregnancies in women with suspected antiphospholipid syndrome. Journal of Neonatal-Perinatal Medicine, 2013, vol. 6, no. 3, pp. 225–230. DOI: 10.3233/NPM-1370113
18. Mekinian A., Lachassinne E., Nicaise-Roland P., Carbillon L., Motta M., Vicaut E., Boinot C., Avcin T., Letoumelin Ph., de Carolis S., Rovere-Querini P., Lambert M., Derenne S., Pourrat O., Stirnemann J., Chollet-Martin S., Biasini-Rebaioli Ch., Rovelli R., Lojacono A., Ambrozic A., Botta A., Benbara A., Pierre F., Allegri F., Nuzzo M., Hatron P.-Y., Tincani A., Fain O., Aurousseau M.-H., Boffa M.-C. European registry of babies born to mothers with antiphospholipid syndrome. Annals of the Rheumatic Diseases, 2013, vol. 72, no. 2, pp. 217–222. DOI: 10.1136/annrheumdis-2011-201167
19. Motta M., Lachassinne E., Boffa M. C., Tincani A., Avcin T., de Carolis S., Aurousseau M. H., le Toumelin P., Lojacono A, de Carolis M. P., Chirico G. European registry of infants born to mothers with antiphospholipid syndrome: preliminary results. Minerva Pediatrica, 2010, vol. 62, no. 3, suppl. 1, pp. 25–27.
20. Serrano F., Nogueira I., Borges A., Branco J. Primary antiphospholipid syndrome: pregnancy outcome in a portuguese population. Acta Reumatológica Portuguesa, 2009, vol. 34, no. 3, pp. 492–497.
21. Jeremic K., Stefanovic A., Dotlic J., Stojnic J., Kadija S., Vilendecic Z., Janjic T., Jeremic J. Neonatal outcome in pregnant patients with antiphospholipid syndrome. Journal of Perinatal Medicine, 2015, vol. 43, no. 6, pp. 761–768. DOI: 10.1515/ jpm-2014-0118
22. Il’ina A. Ya., Shumilov P. V., Mishchenko A. L., Barinova A. S., Kokaya I. Yu., Kashin V. N., Pobedinskaya O. S., Solov’eva I. V., Kharlamova T. S., Budantsev A. V., Akhalova E. A. Thrombophilia as a factor of ethiology and pathogenesys of disorders in the system “woman–fetus–newborn”. Akusherstvo, ginekologiya i reproduktsiya [Obstetrics, gynecology and reproduction], 2016, vol. 10, no. 4, pp. 21–29 (in Russian).
23. Il’ina A. Ya., Shumilov P. V., Turkina T. I., Kirillova N. I., Barinova A. S., Kuzin I. I., Mishchenko A. L., Kokaya I. Yu., Kashin V. N., Pobedinskaya O. S. Antiphospholipid syndrome: hemostasis and lipid metabolism system state in the “woman– fetus–newborn” system. Pediatriya. Zhurnal imeni G. N. Speranskogo [Pediatrics. Journal of G. N. Speransky], 2016, vol. 95, no. 4, pp. 74–84 (in Russian).
24. Boffa M. C., Lachassinne E. Infant perinatal thrombosis and antiphospholipid antibodies: a review. Lupus, 2007, vol. 16, no. 8, pp. 634–641. DOI: 10.1177/0961203307079039
25. De Peixoto M. V., de Carvalho J. F., Rodrigues C. E. M. Clinical, laboratory, and therapeutic analyses of 21 patients with neonatal thrombosis and antiphospholipid antibodies: a literature review. Journal of Immunology Research, 2014, vol. 2014, art. ID 672603. 9 p. DOI: 10.1155/2014/672603
26. Finazzi G., Cortelazzo S., Viero P., Galli M., Barbui T. Maternal lupus anticoagulant and fatal neonatal thrombosis. Thrombosis and Haemostasis, 1987, vol. 57, no. 2, art. no. 238.
27. Sheridan-Pereira M., Porreco R. P., Hays T., Burke M. S. Neonatal aortic thrombosis associated with the lupus anticoagulant. Obstetrics and Gynecology, 1988, vol. 71, no. 6, pt. 2, pp. 1016–1018.
28. Silver R. K., MacGregor S. N., Pasternak J. F., Neely S. E. Fetal stroke associated with elevated maternal anticardiolipin antibodies. Obstetrics and Gynecology, 1992, vol. 80, no. 3, pt. 2, pp. 497–499.
29. Contractor S., Hiatt M., Kosmin M., Kim H. C. Neonatal thrombosis with anticardiolipin antibody in baby and mother American Journal of Perinatology, 1992, vol. 9, no. 5–6, pp. 409–410. DOI: 410. 10.1055/s-2007-999276
30. Tabbutt S., Griswold W. R., Ogino M. T., Mendoza A. E., Allen J. B., Reznik V. M. Multiple thromboses in a premature infant associated with maternal phospholipid antibody syndrome. Journal of Perinatology, 1994, vol. 14, no. 1, pp. 66–70.
31. Hage M. L., Liu R., Marcheschi D. G., Bowie J. D., Allen N. B., B. Macik G. Fetal renal vein thrombosis, hydrops fetalis, and maternal lupus anticoagulant. A case report. Prenatal Diagnosis, 1994, vol. 14, no. 9, pp. 873–877. DOI: 10.1002/ pd.1970140918
32. Teysier G., Gautheron V., Absi L., Galambrun C., Ravni C., Lepetit J. C. Anticorps anticardiolipine, ischémie cérébrale et hémorragie surrénalienne chez un nouveau-né. Archives de Pédiatrie, 1995, vol. 2, no. 11, pp. 1086–1088. DOI: 10.1016/0929693X(96)81285-1
33. De Klerk O. L., de Fries T. W., Sinnige L. G. An unusual cause of neonatal seizures in a newborn infant. Pediatrics, 1997, vol. 100, no. 4, art. E8, 3 p. DOI: 10.1542/peds.100.4.e8
34. Navarro F., Doña-Naranjo M. A., Villanueva I. Neonatal antiphospholipid syndrome. Journal of Rheumatology, 1997, vol. 24, no. 6, pp. 1240–1241.
35. Akanli L. F., Trasi S., Thuraisamy K., Bergtraum M., Thantu A., Fischer R., Cohen-Addad N. Neonatal middle cerebral artery infarction: association with elevated maternal anticardiolipin. American Journal of Perinatology, 1998, vol. 15, no. 6, pp. 399–402. DOI: 10.1055/s-2007-993965
36. Chow G., Mellor D. Neonatal cerebral ischaemia with elevated maternal and infant anticardiolipin antibodies. Developmental Medicine and Child Neurology, 2000, vol. 42, no. 6, pp. 412–413. DOI: 10.1017/s001216220000075x
37. Tuohy J., Harrison A. Prenatal transfer of anticardiolipin antibodies associated with fatal neonatal aortic thrombosis. Australian and New Zealand J. Obstetrics and Gynaecology, 2005, vol. 45, no. 2, pp. 175–176. DOI: 10.1111/j.1479828x.2005.00371.x
38. Soares Rolim A. M., Castro M., Santiago M. B. Neonatal antiphospholipid syndrome. Lupus, 2006, vol. 15, no. 5, pp. 301–303. DOI: 10.1191/0961203306lu2295cr
39. Paro-Panjan D., Kitanovski L., Avcin T. Neonatal antiphospholipid syndrome associated with heterozygous methylentetrahydrofolate reductase C677T and prothrombin G20210A gene mutations. Rheumatology, 2007, vol. 46, no. 4, pp. 720– 721. DOI: 10.1093/rheumatology/kem011
40. De Carolis M. P., Salvi S., Bersani I., de Carolis S. Isolated cerebral sinovenous thrombosis: a rare case of neonatal antiphospholipid syndrome. Indian Pediatrics, 2012, vol. 49, pp. 411–412.
41. Gordon O., Almagor Y., Fridler D., Mandel A., Qutteineh H., Yanir A., Reif Sh., Revel-Vilk Sh. De novo neonatal antiphospholipid syndrome: a case report and review of the literature. Seminars in Arthritis and Rheumatism, 2014, vol. 44, no. 2, pp. 241–245. DOI: 10.1016/j.semarthrit.2014.04.003
42. Magalhães C. S., Suppo de Souza Rugolo L. M., Trindade C. E. P. Neonatal Antiphospholipid Syndrome. NeoReviews, 2014, vol. 15, no. 5, pp. e169–e176. DOI: 10.1542/neo.15-5-e169
43. Bhat M. A., Kawoosa M. S., Bhat J. I., Ali S. W. Antiphospholipid syndrome in a neonate. Pediatric Dermatology, 2011, vol. 28, pp. 342–345. DOI: 10.1111/j.1525-1470.2010.01254.x
44. Alshekaili J., Reynolds G., Cook M. C. De novo infantile primary antiphospholipid antibody syndrome. Lupus, 2010, vol. 19, no. 13, pp. 1565–1568. DOI: 10.1177/0961203310375263
45. Nacinovich R., Galli J., Bomba M., Filippini E., Parrinello G., Nuzzo M., Lojacono A., Motta M., Tincani A. Neuropsychological development of children born to patients with antiphospholipid syndrome. Arthritis and Rheumatism, 2008, vol. 59, no. 3, pp. 345–351. DOI: 10.1002/art.23311
46. Moskalenko M. A. Cerebral palsy in children born to mothers with seropositive and seronegative variant of antiphospholipid syndrome. Abstract of Ph. D. diss. Kharkiv, 2003. 22 p. (in Russian).
47. Moskalenko M. A. Model of pathogenesis and principles of diagnosis of cerebral palsy in children born to mothers with antiphospholipid syndrome. Mediko-sotsial’nye problemy sem’i [Medical and social problems of the family], 2003, vol. 8, no. 2, pp. 92–99.
48. Abisror N., Mekinian A., Lachassinne E., Nicaise-Roland P., de Pontual L., Chollet-Martin S., Boddaert N., Carbillon L., Fain O. Autism spectrum disorders in babies born to mothers with antiphospholipid syndrome. Seminars in Arthritis and Rheumatism, 2013, vol. 43, no. 3, pp. 348–351. DOI: 10.1016/j.semarthrit.2013.07.001
49. Cimaz R., Romeo A., Scarano A., Avin T., Viri M., Veggiotti P., Gatti A., Lodi M., Catelli L., Panzeri P., Cecchini G., Meroni P. L. Prevalence of anti-cardiolipin, anti-β2 glycoprotein I, and anti-prothrombin antibodies in young patients with epilepsy. Epilepsia, 2002, vol. 43, no. 1, pp. 52–59. DOI: 10.1046/j.1528-1157.2002.00701.x
50. Berkun Y., Simchen M. J., Strauss T., Menashcu S., Padeh S., Kenet G. Antiphospholipid antibodies in neonates with stroke – a unique entity or variant of antiphospholipid syndrome? Lupus, 2014, vol. 23, no. 10, pp. 986–993. DOI: 10.1177/0961203314531842
51. Appenzeller S., Lapa A. T., Guirau C. R., de Carvalho J. F., Shoenfeld Y. Cognitive impairment in antiphospholipid syndrome: evidence from animal models. Clinical Rheumatology, 2012, vol. 31, no. 3, pp. 403–406. DOI: 10.1007/s10067-0111922-z
52. Rajagopal R., Cheah F. C., Monagle P. Thromboembolism and anticoagulation management in the preterm infant. Seminars in Fetal and Neonatal Medicine, 2016, vol. 21, no. 1, pp. 50–56. DOI: 10.1016/j.siny.2015.10.005
Review
For citations:
Sukalo A.V., Prilutskaya V.A., Zoryna M.I. HEALTH STATUS OF CHILDREN BORN BY WOMEN WITH ANTIPHOSPHOLIPID SYNDROME. Proceedings of the National Academy of Sciences of Belarus, Medical series. 2018;15(2):229-243. (In Russ.) https://doi.org/10.29235/1814-6023-2018-15-2-229-243
Views: 1409
Email this article 